|
CN1096862C
(zh)
*
|
1994-05-06 |
2002-12-25 |
辉瑞大药厂 |
阿齐霉素的控释剂型
|
|
ES2079327B1
(es)
*
|
1994-12-13 |
1996-08-01 |
Lilly Sa |
Formulaciones farmaceuticas de cefaclor.
|
|
EA003736B1
(ru)
*
|
1995-02-08 |
2003-08-28 |
Яманучи Юроп Б.В. |
Лекарственная форма для перорального введения, содержащая бета-лактамный антибиотик
|
|
US20060003447A1
(en)
*
|
2003-12-30 |
2006-01-05 |
Richard Fike |
Dry powder cells and cell culture reagents and methods of production thereof
|
|
US6383810B2
(en)
*
|
1997-02-14 |
2002-05-07 |
Invitrogen Corporation |
Dry powder cells and cell culture reagents and methods of production thereof
|
|
US20030212123A1
(en)
*
|
1997-05-05 |
2003-11-13 |
Pfizer Inc. |
COX-2 selective carprofen for treating pain and inflammation in dogs
|
|
US6146655A
(en)
*
|
1997-08-29 |
2000-11-14 |
Softy-Flex Inc. |
Flexible intra-oral bandage and drug delivery system
|
|
US6129932A
(en)
*
|
1997-09-05 |
2000-10-10 |
Merck & Co., Inc. |
Compositions for inhibiting platelet aggregation
|
|
US6861411B1
(en)
*
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
|
US5955107A
(en)
*
|
1997-12-12 |
1999-09-21 |
Fmc Corporation |
Pharmaceutical suspension tablet compositions
|
|
JP2001526234A
(ja)
*
|
1997-12-22 |
2001-12-18 |
シェーリング コーポレイション |
経口投与が可能な固形リバビリン投薬の形態およびそれらの製造プロセス
|
|
US5914128A
(en)
*
|
1997-12-22 |
1999-06-22 |
Schering Corporation |
Orally administrable solid dosage form
|
|
US5916594A
(en)
*
|
1997-12-22 |
1999-06-29 |
Schering Corporation |
Process of making solid ribavirin dosage forms
|
|
US6239112B1
(en)
*
|
1998-07-09 |
2001-05-29 |
Merial, Inc. |
Water miscible macrolide solutions
|
|
FR2793690B1
(fr)
*
|
1999-03-30 |
2003-01-03 |
Cll Pharma |
Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
|
|
EA005291B1
(ru)
*
|
1999-03-31 |
2004-12-30 |
Янссен Фармацевтика Н.В. |
Применение предварительно желатинированного крахмала в композиции с контролируемым высвобождением
|
|
US7056893B2
(en)
*
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
|
US6239113B1
(en)
*
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
|
US6528492B1
(en)
*
|
2000-07-25 |
2003-03-04 |
Instituto De Investigacion En Quimica Aplicada S.C. |
Single-step process for preparing 7, 16-deoxy-2-aza-10-0-cladinosil-12-0-desosaminil-4, 5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1) hexadeca-1(2)-en-ona and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
|
|
ATE306491T1
(de)
|
2000-08-23 |
2005-10-15 |
Wockhardt Ltd |
Verfahren zur herstellung von wasserfreiem azithromycin
|
|
EP2295533A3
(en)
*
|
2000-11-06 |
2011-07-13 |
Life Technologies Corporation |
Dry powder cells and cell culture reagents and methods of production thereof
|
|
WO2002040036A1
(fr)
*
|
2000-11-15 |
2002-05-23 |
Masao Sugamata |
Medicaments destines a la prevention ou au traitement de l'endometriose ou du myome uterin
|
|
HRP20010301A2
(en)
*
|
2001-04-27 |
2001-12-31 |
Pliva D D |
New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
|
|
EE200300575A
(et)
*
|
2001-05-22 |
2004-04-15 |
Pfizer Products Inc. |
Asitromütsiini kristalsed vormid
|
|
SI1390377T1
(sl)
|
2001-05-22 |
2006-06-30 |
Pfizer Prod Inc |
Nova kristalna oblika azitromicina
|
|
SK1012004A3
(sk)
*
|
2001-08-21 |
2005-04-01 |
Pfizer Products Inc. |
Použitie azitromycínu na výrobu liečiva na liečenie respiračných infekcií u človeka
|
|
AU2006218279B2
(en)
*
|
2001-09-28 |
2009-12-10 |
Novartis Ag |
Pharmaceutical compositions comprising colloidal silicon dioxide
|
|
GB0123400D0
(en)
|
2001-09-28 |
2001-11-21 |
Novartis Ag |
Organic compounds
|
|
EP1541134A3
(en)
*
|
2001-10-18 |
2007-06-06 |
Teva Pharmaceutical Industries Limited |
Stabilized azithromycin compositions
|
|
HUP0402291A2
(hu)
*
|
2001-10-18 |
2005-03-29 |
Teva Pharmaceutical Industries Ltd. |
Stabilizált azithromycin összetételek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
|
US20080149521A9
(en)
*
|
2001-10-18 |
2008-06-26 |
Michael Pesachovich |
Methods of stabilizing azithromycin
|
|
RU2283651C2
(ru)
*
|
2001-12-21 |
2006-09-20 |
Пфайзер Продактс Инк. |
Способы мокрой грануляции азитромицина
|
|
JP2005513099A
(ja)
*
|
2001-12-21 |
2005-05-12 |
ファイザー・プロダクツ・インク |
アジスロマイシンの直接的に圧縮可能な配合品
|
|
JP2006501137A
(ja)
*
|
2002-01-16 |
2006-01-12 |
ペプジェン コーポレイション |
インターフェロン−τの経口投与
|
|
EP1478347A1
(en)
*
|
2002-02-01 |
2004-11-24 |
Pfizer Products Inc. |
Dry granulated formulations of azithromycin
|
|
EP1490031A1
(en)
*
|
2002-03-07 |
2004-12-29 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
GB0209265D0
(en)
|
2002-04-23 |
2002-06-05 |
Novartis Ag |
Organic compounds
|
|
BG748Y1
(bg)
*
|
2002-07-02 |
2005-06-30 |
"BALKANFARMA-RAZGRAD" AD A{ô{òM{}ö{ }{GC}{D A{DAAAAAAAAAAAAAAAAAAAAAAAAAA |
ЛЕКАРСТВЕНАБФОРМАБББББББББББББББББББББББББББББББББФЕДЙГБФЕХгЦдв@ЖЦЩФ@@@@@@@@@@@
|
|
EP1594762A1
(en)
*
|
2003-02-19 |
2005-11-16 |
Teva Pharmaceutical Industries Limited |
Methods of stabilizing azithromycin during storage by packaging in a gas impermeable container
|
|
US8507000B2
(en)
*
|
2003-05-06 |
2013-08-13 |
Nostrum Pharmaceuticals, Inc. |
Controlled release formulation of erythromycin derivatives
|
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
|
EP1648473B1
(en)
*
|
2003-07-24 |
2009-01-28 |
PLIVA HRVATSKA d.o.o. |
Single dose fast dissolving azithromycin
|
|
TWI366442B
(en)
|
2003-07-30 |
2012-06-21 |
Novartis Ag |
Palatable ductile chewable veterinary composition
|
|
US20050089502A1
(en)
*
|
2003-08-21 |
2005-04-28 |
Todd Schansberg |
Effervescent delivery system
|
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
|
JP2007513143A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
押出機を使用して好ましくはポロクサマーおよびグリセリドを含む多粒子アジスロマイシン組成物を製造するための噴霧凝固法
|
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
|
BRPI0417348A
(pt)
*
|
2003-12-04 |
2007-03-13 |
Pfizer Prod Inc |
processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
|
|
ATE399536T1
(de)
*
|
2003-12-04 |
2008-07-15 |
Pfizer Prod Inc |
Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
|
|
UA78793C2
(en)
*
|
2003-12-04 |
2007-04-25 |
Pfizer Prod Inc |
Oral dosage form of azitromycin with decreased side effects
|
|
CA2547597A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate compositions with improved stability
|
|
CA2547239A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Azithromycin multiparticulate dosage forms by liquid-based processes
|
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
|
US20050131079A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Pujara Chetan P. |
Cefdinir oral suspension
|
|
WO2005067500A2
(en)
*
|
2003-12-30 |
2005-07-28 |
3M Innovative Properties Company |
Enhancement of immune responses
|
|
US7468428B2
(en)
*
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
JP4713104B2
(ja)
*
|
2004-08-04 |
2011-06-29 |
ファイザー株式会社 |
アジスロマイシン類を有効成分とする苦味が抑制された安定な組成物
|
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
|
US20060182806A1
(en)
*
|
2004-11-08 |
2006-08-17 |
Mintong Guo |
Extended-release propranolol composition
|
|
WO2006080029A1
(en)
*
|
2005-01-27 |
2006-08-03 |
Alembic Limited |
Extended release formulation of levetiracetam
|
|
US20060198895A1
(en)
*
|
2005-03-07 |
2006-09-07 |
Kotliar Eleonora M |
Azithromycin powder for oral suspension compositions
|
|
CN101171017A
(zh)
*
|
2005-03-07 |
2008-04-30 |
特瓦制药工业有限公司 |
阿奇霉素口服混悬液用散剂组合物
|
|
DK1884242T3
(da)
|
2005-05-26 |
2013-05-06 |
Dainippon Sumitomo Pharma Co |
Farmaceutisk sammensætning omfattende lurasidon
|
|
WO2007018192A1
(ja)
*
|
2005-08-10 |
2007-02-15 |
Shionogi & Co., Ltd. |
口腔内崩壊錠剤
|
|
US20070191271A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Dow Pharmaceutical Sciences |
Method for stabilizing polypeptides lacking methionine
|
|
US8187659B2
(en)
|
2006-05-02 |
2012-05-29 |
Jerry Robertson Real Estate Llc |
Solid medicament dosage form consumption aid
|
|
US20080014264A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Ucb, S.A. |
Novel pharmaceutical compositions comprising levetiracetam
|
|
US8124123B2
(en)
*
|
2007-09-05 |
2012-02-28 |
Dow Pharmaceutical Sciences, Inc. |
Controlled release azithromycin solid dosages forms
|
|
TWI478712B
(zh)
|
2008-09-30 |
2015-04-01 |
Astellas Pharma Inc |
釋控性醫藥組成物
|
|
US20120070465A1
(en)
|
2010-03-29 |
2012-03-22 |
Astellas Pharma Inc. |
Pharmaceutical composition for modified release
|
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
|
ME03323B
(me)
|
2012-02-06 |
2019-10-20 |
Merial Inc |
Paraziticidne oralne veterinarske kompozicije koje sadrže sistemski djelujuća aktivna sredstva, metodi i primjene istih
|
|
WO2013129889A2
(ko)
|
2012-02-28 |
2013-09-06 |
주식회사 서울제약 |
실데나필을 유효성분으로 함유하며 고미가 은폐된 고함량 속용필름
|
|
RU2498805C1
(ru)
*
|
2012-07-23 |
2013-11-20 |
Открытое акционерное общество "Биосинтез" |
Твердая лекарственная форма азитромицина
|
|
CN104177457A
(zh)
*
|
2013-05-23 |
2014-12-03 |
长春海悦药业有限公司 |
一种阿奇霉素药物原料及其制剂和用途
|
|
WO2015070131A1
(en)
*
|
2013-11-11 |
2015-05-14 |
Forest Laboratories Holdings Limited |
Compositions and methods of treatment comprising fosfomycin disodium
|
|
RU2649834C1
(ru)
*
|
2016-07-06 |
2018-04-04 |
Фармалидер С.А. |
Фармацевтическая композиция силденафила цитрата в форме суспензии для перорального применения
|
|
US12097189B1
(en)
|
2024-02-09 |
2024-09-24 |
Astellas Pharma Inc. |
Pharmaceutical composition for modified release
|